TamGen:通过化学语言模型设计药物设计,通过目标感知分子生成
Kehan Wu1, Yingce Xia2, Pan Deng3
1University of Science and Technology of China, Hefei, China.
Nature communications
|October 30, 2024
概括
TamGen是一种新的生成药物设计方法,可以创建高质量的分子,以致病原蛋白为目标. 这种方法成功地确定了结核病ClpP蛋白酶的强大抑制剂,推进了治疗策略.
科学领域:
- 药用化学 医学化学
- 计算化学的计算化学
- 药物发现 药物发现 药物发现
背景情况:
- 生成性药物设计为新疗法提供了潜力,但通常会产生具有有限实际可行性的分子.
- 现有的方法经常忽略关键的药物相关性质,阻碍下游药物发现的成功.
研究的目的:
- 开发TamGen,一种使用类似GPT的化学语言模型进行目标感知分子生成和精炼的方法.
- 提高药物发现产生的化合物的分子质量和可行性.
主要方法:
- 用一种类似GPT的化学语言模型来进行生成性药物设计.
- 将TamGen集成到药物发现管道中,用于特定目标的化合物识别.
- 采用了针对目标的分子生成和化合物精炼策略.
主要成果:
- 由TamGen生成的化合物表现出改善的分子质量和活力.
- 确定了14种具有对结核病ClpP蛋白酶抑制活性的化合物.
- 这种化合物显示出半最大抑制度 (IC50) 为1.9μM.
结论:
- 塔姆基因增强了生成性药物设计的实用性.
- 该方法显示了发现有效治疗剂的现实潜力.
- 这些发现为计算药物发现的未来进步铺平了道路.
更多相关视频
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
2.4K
10:49Identification of Small Molecule-binding Proteins in a Native Cellular Environment by Live-cell Photoaffinity Labeling
Published on: September 20, 2016
12.6K
相关概念视频
Drug Discovery: Overview
7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
Structure-Activity Relationships and Drug Design
622
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
622
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
Principles of Drug Action
5.9K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.9K
Molecular Models
38.0K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
38.0K
Drug-Receptor Bonds
2.7K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.7K
